Category: Critical Care
Keywords: HAART HIV AIDS Critical illness (PubMed Search)
Posted: 9/27/2010 by Haney Mallemat, MD
Click here to contact Haney Mallemat, MD
While you should always involve ID consultants when managing critically-ill HIV/AIDS patients on HAART, consider this; sub-therapeutic levels of anti-retrovirals may promote HIV resistance, potentially invalidating a class of drug for future use. Therefore, it may be advantageous to discontinue the drug(s) during critical-illness to avoid resistance.
Two examples leading to sub-therapeutic HAART levels in critical-illness:
Current issues in critical care of the human immunodeficiency virus-infected patient. Morris A, Masur H, Huang L Crit Care Med. 2006 Jan;34(1):42-9.
Download the UMEM Pearls App!
Subscribe to daily UMEM Pearls (FREE!) via: